Insulet expects to become profitable within two years despite stiff competition and a drop in consumer spending, said Chief Financial Officer Brian Roberts. The company is negotiating with potential partners to distribute its wireless insulin pump, OmniPod, in Europe and Asia. Insulet also is adding a continuous glucose-monitoring feature to the device to retain the product's competitive edge.

Full Story:

Related Summaries